| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000004034A2 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/27/2000 | WO2000004031A1 Phosphorous organic compounds and their use |
| 01/27/2000 | WO2000004008A1 Novel cyp2d fluorescent assay reagents |
| 01/27/2000 | WO2000003727A1 Engineered proteins for analyte sensing |
| 01/27/2000 | WO2000003725A1 Method for identifying and confirming consistent bio-functionality of natural compositions |
| 01/27/2000 | WO2000003699A2 Drugs containing phosphoric acid derivatives as active ingredient and their use |
| 01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | WO1999064604A3 Attenuated pestiviruses |
| 01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 01/27/2000 | WO1999061665A3 Solution hybridization of nucleic acids with antisense probes having modified backbones |
| 01/27/2000 | WO1999061639A3 Retroviral delivery system |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | WO1999054510A3 Quantitative analysis of gene expression |
| 01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
| 01/27/2000 | WO1999039735A9 Live vaccine for human immunodeficiency virus |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | DE19832050A1 Detection of Hepatitis C and B viral genomes in serum or plasma using specific oligonucleotide primers and probes |
| 01/27/2000 | DE19832007A1 Differentiation of living and dead microorganisms by fluorescence microscopy after fixing and staining with acridine orange |
| 01/27/2000 | DE19831637A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 01/27/2000 | DE19831043A1 Hemmung von Alopezie Inhibition of alopecia |
| 01/27/2000 | CA2720311A1 A method of producing cells with a desired property by recursive sequence recombination |
| 01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337353A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | CA2337045A1 Cis acting nucleic acid elements and methods of use |
| 01/27/2000 | CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2335324A1 Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
| 01/27/2000 | CA2335101A1 Androgen receptor coactivators |
| 01/27/2000 | CA2335099A1 New caspase homologue |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334045A1 Adenoviral based promoter assay |
| 01/27/2000 | CA2334039A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333917A1 71 human secreted proteins |
| 01/27/2000 | CA2333912A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333856A1 Serotype-specific probes for listeria monocytogenes |
| 01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2332722A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/27/2000 | CA2270797A1 Transparent flow through membrane for dry reagent analytical devices |
| 01/26/2000 | EP0974842A1 Reagent for examining agglutination of virus and kit for virus examination |
| 01/26/2000 | EP0974672A1 Improved primers for AFLP amplification |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974660A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 01/26/2000 | EP0974658A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(STREPTOCOCCUS PYOGENES) |
| 01/26/2000 | EP0974649A1 Screening system |
| 01/26/2000 | EP0974303A1 Method and instrument for measuring blood sugar level |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0974055A1 Titration method for a complex viral composition |
| 01/26/2000 | EP0974052A1 Substances to correct aberrant gene product fonction |
| 01/26/2000 | EP0973948A2 Nucleic acid based detection of cytomegalovirus |
| 01/26/2000 | EP0973947A1 System for detecting nucleic acid hybridisation, preparation method and application thereof |
| 01/26/2000 | EP0973946A1 Biological assay for testing the carcinogenic properties of a substance |
| 01/26/2000 | EP0973945A1 Chiral peptide nucleic acids and methods for preparing same |
| 01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 01/26/2000 | EP0973943A1 Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| 01/26/2000 | EP0973942A2 Screening method for proline-rich proteins |
| 01/26/2000 | EP0973941A1 Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (hcc), as well as diagnostic methods using the same |
| 01/26/2000 | EP0973940A1 AN $i(IN VITRO) METHOD FOR CONSTRUCTION OF A DNA LIBRARY |
| 01/26/2000 | EP0973939A1 Expression monitoring for gene function identification |
| 01/26/2000 | EP0973938A1 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites |
| 01/26/2000 | EP0973937A1 Method of selectively determining a fungal biomass |
| 01/26/2000 | EP0973936A1 Combinatorial libraries of peptidomimetic aminothioether acids |
| 01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
| 01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
| 01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
| 01/26/2000 | EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods |
| 01/26/2000 | EP0973885A1 Disassociation of interacting molecules |
| 01/26/2000 | EP0973884A1 Phosphate-deficiency inducible promoter |
| 01/26/2000 | EP0973877A4 Improved support layer for enzyme electrode laminated membranes |
| 01/26/2000 | EP0973877A1 Improved support layer for enzyme electrode laminated membranes |
| 01/26/2000 | EP0973874A2 Enzyme assay for mutant firefly luciferase |
| 01/26/2000 | EP0973868A1 Evaluation of changes in breast cells using nipple aspirate fluid |
| 01/26/2000 | EP0973800A1 Novel receptor |
| 01/26/2000 | EP0973791A2 Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds |
| 01/26/2000 | EP0973788A1 Tricyclic base analogues |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973547A1 Improving binding affinity of antigenic peptides for mhc molecules |
| 01/26/2000 | EP0973536A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
| 01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 01/26/2000 | EP0600877B1 Selection of ribozymes that efficiently cleave target rna |
| 01/26/2000 | CN1242803A Glyphosate resistant transgenic plants |
| 01/26/2000 | CN1242775A G-rich oligo aptamers and methods of modulating immune response |
| 01/26/2000 | CN1242431A Improved difference displaying polymerase chain reaction method |
| 01/26/2000 | CN1242430A Macro-fragment deoxyribonucleic acid core piece and method for mfg. same |
| 01/26/2000 | CN1242429A Papain blood group diagnose reagent prepn. method |
| 01/26/2000 | CN1048756C Measurement of mold growth on amorphous substrates |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018587 Method for remote sensing analysis be decorrelation statistical analysis and hardware therefor |